|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/08 | |
| G01N 33/569 |
| (11) | Number of the document | 2938631 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14700033.5 |
| Date of filing the European patent application | 2014-01-02 | |
| (97) | Date of publication of the European application | 2015-11-04 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/050024 |
| Date | 2014-01-02 |
| (87) | Number | WO 2014/102399 |
| Date | 2014-07-03 |
| (30) | Number | Date | Country code |
| 12199837 | 2012-12-31 | EP | |
| 201261747541 P | 2012-12-31 | US |
| (72) |
GRIMM, Jan, CH
MARTIN, Roland, CH
COMBALUZIER, Benoit, CH
JELCIC, Ivan, Dr., CH
|
| (73) |
University of Zurich,
Rämistr. 71, 8006 Zurich,
CH
Neurimmune Holding AG, Wagistrasse 13, 8952 Schlieren, CH |
| (54) | RECOMBINANT HUMAN ANTIBODIES FOR THERAPY AND PREVENTION OF POLYOMAVIRUS-RELATED DISEASES |
| RECOMBINANT HUMAN ANTIBODIES FOR THERAPY AND PREVENTION OF POLYOMAVIRUS-RELATED DISEASES |